Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

End-of-study results from the ICON3 pines trial, a phase 3, randomized trial of eltrombopag vs. standard first-line treatment for newly diagnosed immune thrombocytopenia in children

Blood (2025) 146 (Supplement 1): 738.

https://doi.org/10.1182/blood-2025-738

Published: 2025

Journal Articles

Germline genetic testing uncovers a high frequency of inborn error of immunity diagnoses in children with single and multi-lineage immune cytopenias in a large US cohort

Emily Harris, Thomas Pincez, Kirsty Hillier, Yi-Lee Ting, Jennifer MacWhirter - DiRaimo, Hannah Helber, Candelaria O'Farrell, Estelle Lecluze, Taylor Kim, Rachael Grace, Michael Scheurer, Rebecca Hale, Kristin Shimano, Diane Nugent, Ellis Neufeld, Craig Platt, Michele Lambert, Amanda Grimes, Shipra Kaicker

Blood (2025) 146 (Supplement 1): 630.

https://doi.org/10.1182/blood-2025-630

Published: 2025

Journal Articles

Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS)

Cindy E. Neunert, George R. Buchanan, Paul Imbach, Paula H. B. Bolton-Maggs, Carolyn M. Bennett, Ellis Neufeld, Sara K. Vesely, Leah Adix, Victor S. Blanchette, Thomas Kühne

Blood (2013) 121 (22): 4457–4462.

https://doi.org/10.1182/blood-2012-12-466375

Published: 2013

Journal Articles

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

Vivek L. Patel, Matthieu Mahévas, Soo Y. Lee, Roberto Stasi, Susanna Cunningham-Rundles, Bertrand Godeau, Julie Kanter, Ellis Neufeld, Tillmann Taube, Ugo Ramenghi, Shalini Shenoy, Mary J. Ward, Nino Mihatov, Vinay L. Patel, Philippe Bierling, Martin Lesser, Nichola Cooper, James B. Bussel

Blood (2012) 119 (25): 5989–5995.

https://doi.org/10.1182/blood-2011-11-393975

Published: 2012

Journal Articles

Health-Related Quality of Life (HRQL) in Children with Severe, Chronic Immune Thrombocytopenia (cITP) Treated with Rituximab.

Susan Parsons, MD, MRP, Carolyn Bennett, MD, Donald Mahoney, MD, Thomas Olson, MD, Hadi Sawaf, MD, Theodore Moore, MD, Mignon Loh, MD, George Buchanan, MD, Ellis Neufeld, MD, PhD.

Blood (2005) 106 (11): 5575.

https://doi.org/10.1182/blood.V106.11.5575.5575

Published: 2005

Journal Articles

High Prevalence of Fractures and Bone Pain in Thalassemia: The Thalassemia Clinical Research Network Experience.

Maria Vogiatzi, MD, Eric Macklin, PhD, Robert Schneider, MD, Joseph Lane, MD, Nancy Olivieri, MD, Melanie Kirby, MD, Angela Cheung, MD, Elliott Vichinsky, MD, Ellen Fung, PhD, Alan Cohen, MD, Janet Kwiatkowski, MD, Virginia Stallings, MD, Ingrid Holm, MD, Ellis Neufeld, MD, Patricia J. Giardina, MD

Blood (2005) 106 (11): 2706.

https://doi.org/10.1182/blood.V106.11.2706.2706

Published: 2005

Journal Articles

Control of Oxidant-Stress and Inflammation by Iron Chelators Deferasirox (ICL670) or Deferoxamine in β-Thalassemia: An Ancillary Study of the Novartis CICL670A0107 Trial.

Patrick Walter, PhD, Eric Macklin, PhD, John Porter, MD, Patricia Evans, PhD, Tom Coates, MD, Nancy F. Olivieri, MD, Patricia Giardina, MD, Janet Kwiatkowski, MD, Ellis Neufeld, MD, Bruce Ames, PhD, Jaymes Holland, Peter Marks, MD, Elliott Vichinsky, MD, Paul Harmatz, MD

Blood (2005) 106 (11): 3598.

https://doi.org/10.1182/blood.V106.11.3598.3598

Published: 2005

Journal Articles

Quantitative Assessment of Drug Treatment Side Effects in Children with Idiopathic Thrombocytopenic Purpura (ITP).

George Buchanan, MD, Leah Adix, BS, Robert Klaassen, MD, Ellis Neufeld, MD, Ph.D., Sherri Zimmerman, MD, Kimo Stine, MD

Blood (2004) 104 (11): 3030.

https://doi.org/10.1182/blood.V104.11.3030.3030

Published: 2004

Journal Articles

Myocardial iron measurements by MRI: getting to the heart of the matter

Ellis Neufeld

Blood (2004) 103 (5): 1571.

https://doi.org/10.1182/blood-2003-12-4440

Published: 2004

Journal Articles

Starting out right: Kozak sequences and clots

Ellis Neufeld

Blood (2002) 100 (6): 1933.

https://doi.org/10.1182/blood-2002-07-2202

Published: 2002

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

End-of-study results from the ICON3 pines trial, a phase 3, randomized trial of eltrombopag vs. standard first-line treatment for newly diagnosed immune thrombocytopenia in children

Germline genetic testing uncovers a high frequency of inborn error of immunity diagnoses in children with single and multi-lineage immune cytopenias in a large US cohort

Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS)

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

Health-Related Quality of Life (HRQL) in Children with Severe, Chronic Immune Thrombocytopenia (cITP) Treated with Rituximab.

High Prevalence of Fractures and Bone Pain in Thalassemia: The Thalassemia Clinical Research Network Experience.

Control of Oxidant-Stress and Inflammation by Iron Chelators Deferasirox (ICL670) or Deferoxamine in β-Thalassemia: An Ancillary Study of the Novartis CICL670A0107 Trial.

Quantitative Assessment of Drug Treatment Side Effects in Children with Idiopathic Thrombocytopenic Purpura (ITP).

Myocardial iron measurements by MRI: getting to the heart of the matter

Starting out right: Kozak sequences and clots

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only